This article first appeared on GuruFocus.
After a Rome court ruled that Netflix (NFLX, Financials) raised subscription prices from 2017 to 2024 in violation of consumer protection laws, the company is at greater legal risk in Italy.
The court said that Netflix's contract terms didn't clearly explain why those prices went up. The decision could mean that millions of current and former users get their money back.
The court also told Netflix to lower prices for users who were affected. The price of a premium plan could go down from 19.99 to 11.99, and the price of a standard plan could go down from 13.99 to 9.99.
Lawyers for the consumer group said premium users who had been paying since 2017 could get back up to 500. Users of the standard plan could get about 250.
The court also told Netflix to tell affected users, including former subscribers, and to post the decision on its website and in the national press.
Netflix has said that it thinks its terms were in line with Italian law and plans to appeal. The company hasn't responded to the latest order to lower prices.
LATEST POSTS
- 1
Recalled Super Greens diet supplement powder sickens 45 with salmonella - 2
Ergonomic Office Seats for Work spaces - 3
‘Slender Man’ attacker back in custody. What we know about Morgan Geyser's disappearance and what happens next. - 4
Is Chinese food truly flavorful? - 5
Eight Muslim nations condemn Israel's 'dangerous' new death penalty law
How one man's concern saved his brothers from heart disease
Launch pad damaged as Russian rocket blasts off for space station, agency says
BravoCon 2025: How to watch, full schedule and lineup, where to stream free and more
10 Delectable Specialty Mixed drinks
Scientists reveal earliest evidence for shifting of Earth’s crust
Volkswagen Just Revealed a Massive Range-Extended SUV for China, and America Isn’t Getting It
Jury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders
From Squid Game to Your Party! Six Entertaining Test Games That Will Have You in Join
Lilly, Novo lock horns in India's obesity drug race













